636 studies on GLP-1 agonist class curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research is critically important because it addresses a significant unmet need for overweight type 2 diabetic patients with IBD, a population facing compounded health challenges. Current IBD therapies are often l…
Understanding ethnic differences in drug response is critical for optimizing dosing and ensuring drug safety globally. Data from studies like this help inform appropriate prescribing practices for diverse populations,…
If successful, this study could highlight a novel therapeutic benefit of semaglutide beyond its established roles in glycemic control and weight management. Identifying an effective pharmacological intervention for di…
While specific numerical outcomes from this completed trial (NCT03882970) are not detailed in the provided record, the study's primary objective was to demonstrate the superior efficacy of tirzepatide in improving gly…
This research holds significant promise as tirzepatide could represent an innovative approach to effectively induce weight loss and inhibit tumor growth in obesity-driven endometrial cancer. Given the strong link betw…
This case report is significant as it contributes to the emerging understanding of tirzepatide's potential adverse effects, specifically hepatotoxicity. The finding highlights the importance for clinicians to consider…
This review underscores the profound and expanding therapeutic potential of GLP-1 receptor agonists, solidifying their role as cornerstone treatments for type 2 diabetes and obesity. The confirmed cardiovascular and r…
This study's design was significant because it aimed to provide a head-to-head comparison of two distinct and highly effective drug classes—a GLP-1 receptor agonist and an SGLT2 inhibitor—in a critical patient populat…
This research holds significant promise for public health, as it targets a critical window for intervention to prevent Type 2 Diabetes (T2DM) in a high-risk group. Successful outcomes could establish semaglutide as a …
Understanding the precise gastric emptying kinetics in both healthy individuals and GLP-1 agonist users is critically important for optimizing treatment strategies and patient safety. The findings could lead to update…
This trial is crucial because it directly addresses a significant unmet need in treating HFpEF, especially in the context of obesity. If successful, it could establish Semaglutide as a novel therapeutic strategy for i…
If BGM0504 demonstrates comparable or superior efficacy and safety to Tirzepatide, it could represent a significant advancement in the treatment landscape for obesity. A new therapeutic option would provide clinicians…
The termination of this Phase 2 study means a potential avenue for enhanced obesity treatment in older adults remains unexplored. While tirzepatide is highly effective, combination therapies are often sought to improv…
This Randomized Control Trial is highly significant as it explores a novel strategy to enhance the effectiveness of bariatric surgery, potentially offering a more robust solution for severe obesity. If successful, com…
The findings from this trial could have a profound impact on the treatment landscape for Type 2 Diabetes. If CagriSema demonstrates superior or even comparable efficacy with a favorable safety profile, it could become…
The termination of a Phase 2 trial for a novel compound like PF-07081532 is a significant event in drug development, often signaling issues with safety, efficacy, or strategic priorities. While the specific reasons fo…
This planned randomized clinical trial holds significant promise for addressing the growing public health challenge of cognitive decline in older adults with Type 2 diabetes. If successful, the findings could provide …
This study is significant because it directly addresses the need for ethnically diverse clinical data in obesity treatment. The findings will provide crucial insights into how Semaglutide 2.4mg performs in the Latino …
Understanding the interplay between GLP-1 receptor agonists like semaglutide and the ghrelin system is crucial for optimizing obesity treatments. If blocking the ghrelin receptor with LEAP2 proves beneficial, it could…
This research holds significant promise as it investigates a novel approach to treating psoriasis by targeting its metabolic underpinnings, rather than just skin symptoms. If successful, it could demonstrate that Sema…
This study is crucial for enhancing patient safety during surgical procedures for individuals on GLP-1 agonists. The findings will help identify specific patient populations who require additional risk stratification,…
The withdrawal of this study means a valuable opportunity to directly compare these important first-line diabetes treatments has been lost. Had it proceeded, the trial could have provided critical head-to-head data, p…
This research is profoundly important as Type 2 Diabetes (T2D) significantly elevates the risk of severe cerebrovascular events like stroke, and understanding semaglutide's direct impact on brain health is critical. I…
The high and increasing prevalence of adolescent severe obesity underscores the urgent need for more effective and sustainable treatment strategies. If successful, this trial could demonstrate that combining semagluti…
This study is profoundly crucial for validating the cardiovascular benefits of semaglutide 2.4 mg in a real-world setting, offering invaluable data that complements and extends findings from highly controlled clinical…
Understanding the optimal pre-procedural management for patients on GLP-1RAs like semaglutide is critical for patient safety and procedural efficacy during endoscopy. If a one-week discontinuation significantly reduce…
This trial is critically important because it directly compares the anti-atherosclerotic potential of newer, cardio-protective antidiabetic drugs against a long-standing standard in a high-risk population. If semaglut…
This research is important because it provides real-world evidence for oral semaglutide's effectiveness outside of highly controlled clinical trial settings. Understanding its performance in routine clinical practice,…
This study is significant because it specifically investigates Semaglutide's efficacy and safety in East Asian subjects, addressing a critical gap in demographic representation within clinical trials for overweight an…
The potential findings from this study could be transformative for obesity management, offering a strategy to mitigate the undesirable muscle loss often associated with significant weight reduction. If successful, thi…